1228994-66-8 Usage
Explanation
The compound consists of 8 carbon atoms, 10 hydrogen atoms, and 2 nitrogen atoms.
Explanation
It contains both carbon and nitrogen atoms arranged in a ring structure, with the nitrogen atoms interrupting the carbon-only ring.
Explanation
The compound has a pyridine ring (a six-membered nitrogen-containing ring) fused to a pyrazole ring (a five-membered nitrogen-containing ring).
Explanation
This chemical compound is not found in nature and is synthesized in a laboratory setting.
Explanation
1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine is created through chemical reactions in a controlled laboratory environment.
Explanation
Due to its unique structure and properties, this compound may have potential uses in the development of new drugs and medications.
Explanation
The compound may be useful as an intermediate or building block in the synthesis of other organic compounds, as well as in chemical manufacturing processes.
Explanation
More research is needed to fully understand the potential uses and properties of 1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine.
Type of compound
Heterocyclic organic compound
Structure
Pyridine ring fused to a pyrazole ring
Natural occurrence
Not naturally occurring
Synthesis
Laboratory synthesis
Potential applications
Pharmaceutical research and drug development
Other possible uses
Organic synthesis and chemical manufacturing
Need for further research
Yes
Check Digit Verification of cas no
The CAS Registry Mumber 1228994-66-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,9,9 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1228994-66:
(9*1)+(8*2)+(7*2)+(6*8)+(5*9)+(4*9)+(3*4)+(2*6)+(1*6)=198
198 % 10 = 8
So 1228994-66-8 is a valid CAS Registry Number.
1228994-66-8Relevant articles and documents
PRMT5 INHIBITORS AND USES THEREOF
-
Paragraph 00415, (2014/07/08)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described
